InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

OSEC Insider Trading

Insider Ownership Percentage: 0.24%
Insider Buying (Last 12 Months): £54,183
Insider Selling (Last 12 Months): GBX 0

Octopus AIM VCT 2 Insider Trading History Chart

This chart shows the insider buying and selling history at Octopus AIM VCT 2 by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Octopus AIM VCT 2 Share Price & Price History

Current Price: GBX 45.40
Price Change: +0.30 (1.20%)
As of 11/28/2023 10:22 PM ET

This chart shows the closing price history over time for OSEC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Octopus AIM VCT 2 Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/9/2023Keith Richard MullinsInsiderBuy108,366GBX 50£54,183
10/7/2021Keith Richard MullinsInsiderBuy104,368GBX 103£107,499.04
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Octopus AIM VCT 2 (LON:OSEC)

Octopus AIM VCT 2 plc is a venture capital trust specializing in investments in AIM quoted companies. It seeks to invest in various sectors such as financial services, healthcare equipment, food producers, business services, pharmaceuticals and biotechnology, travel and leisure, industrial engineering, oil equipment, support services, general retailers, software, and media. The fund typically makes investments in the United Kingdom region. It typically makes investments between $23.27 million and $465.38 million.
Read More on Octopus AIM VCT 2

Today's Range

Now: GBX 45.40
Low: 44.40
High: 45.40

50 Day Range

MA: GBX 46.22
Low: 43.60
High: 49.90

52 Week Range

Now: GBX 45.40
Low: 43.60
High: 60

Volume

2,051 shs

Average Volume

17,505 shs

Market Capitalization

£73.82 million

P/E Ratio

N/A

Dividend Yield

7.41%

Beta

0.58

Who are the company insiders with the largest holdings of Octopus AIM VCT 2?

Octopus AIM VCT 2's top insider shareholders include:
  1. Keith Richard Mullins (Insider)
Learn More about top insider investors at Octopus AIM VCT 2.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.